U. Martin Fuhs's most recent trade in Alpine Immune Sciences Inc was a trade of 52,180 Stock Option (Right to buy) done . Disclosure was reported to the exchange on May 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alpine Immune Sciences Inc | U. Martin Fuhs | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 52,180 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | U. Martin Fuhs | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 28,700 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | U. Martin Fuhs | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 22,820 | 7,300 (0%) | 0% | - | Common Stock | |
| Alpine Immune Sciences Inc | U. Martin Fuhs | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 14,600 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | U. Martin Fuhs | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,300 | 0 (0%) | 0% | - | Common Stock | |
| Alpine Immune Sciences Inc | U. Martin Fuhs | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 22,820 | 52,180 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | U. Martin Fuhs | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.07 per share. | 08 May 2024 | 22,820 | 30,120 (0%) | 0% | 12.1 | 275,437 | Common Stock |